Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

315 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-31

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

NCT03244826

Other Cancer

COMPLETED NA

Behavioral Intervention For BMT/SCT Survivors

NCT00579917

Hodgkin's Disease Leukemia Multiple Myeloma +1 more

COMPLETED

Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer

NCT00126477

Leukemia Lymphoma Myelodysplastic Syndromes +1 more

COMPLETED

Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant

NCT01084694

Depression Anxiety Fatigue +1 more

COMPLETED

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

NCT01890486

Acute Myelogenous Leukemia Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia +7 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leukemia Acute Leukemia Acute Lymphocytic Leukemia Multiple Myeloma Hematological Cancers Psychological Distress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Writing Type 1

Group Type EXPERIMENTAL

Writing A (Experimental informative writing)

Intervention Type BEHAVIORAL

Experimental informative writing

Experimental Writing type 2

Group Type EXPERIMENTAL

Writing B (Experimental noninformative writing)

Intervention Type BEHAVIORAL

Experimental noninformative writing

Control writing type 1

Group Type ACTIVE_COMPARATOR

Writing C (Control informative writing)

Intervention Type BEHAVIORAL

Control informative writing

Control writing type 2

Group Type PLACEBO_COMPARATOR

Writing D (Control noninformative writing)

Intervention Type BEHAVIORAL

Control noninformative writing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Writing A (Experimental informative writing)

Experimental informative writing

Intervention Type BEHAVIORAL

Writing B (Experimental noninformative writing)

Experimental noninformative writing

Intervention Type BEHAVIORAL

Writing C (Control informative writing)

Control informative writing

Intervention Type BEHAVIORAL

Writing D (Control noninformative writing)

Control noninformative writing

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed
* Be at least 18 years old now (and at least 16 when they had their transplant)
* Speak English
* Have telephone service